Jun Zhu
机构:Peking University, Peking University Cancer Hospital, Ministry of Education · ORCID:0000-0003-3479-2547
发表论文 319 篇 · 总被引 7850 次 · h-index 40
代表论文
- Reprocessable non-isocyanate polyurethane foams from lignin: A sustainable route to high-performance thermal insulation materials (2025 · Chemical Engineering Journal · 被引 8)
- Tifcemalimab as monotherapy or in combination with toripalimab in patients with relapsed/refractory lymphoma: a Phase I trial (2025 · Nature Communications · 被引 6)
- Phase 2 study of relmacabtagene autoleucel (CD19 CAR-T) for relapsed/refractory mantle cell lymphoma in Chinese adults (2025 · Blood Advances · 被引 5)
- EZH2 inhibitor SHR2554 enhances the anti-tumor efficacy of HDAC inhibitor Chidamide through STAT1 in T-cell lymphoma (2025 · Cell Death and Disease · 被引 5)
- Efficacy and safety of rocbrutinib, a highly selective 4th-generation BTK inhibitor, in Chinese patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) (2025 · Blood · 被引 3)
- Interleukin-2-inducible T-cell kinase inhibition to block NF-κB signaling exerts anti-tumor effects and enhances chemotherapy in NK/T-cell lymphoma (2025 · Cancer Letters · 被引 3)